Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H24FN3O3 |
| Molecular Weight | 385.432 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(N2C[C@@H]3CCCN[C@@H]3C2)C(F)=CN4C(=O)C(=CC(C5CC5)=C14)C(O)=O
InChI
InChIKey=LPFFKRSIFTURFF-SUMWQHHRSA-N
InChI=1S/C21H24FN3O3/c1-11-18-14(12-4-5-12)7-15(21(27)28)20(26)25(18)9-16(22)19(11)24-8-13-3-2-6-23-17(13)10-24/h7,9,12-13,17,23H,2-6,8,10H2,1H3,(H,27,28)/t13-,17+/m0/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The 2-pyridone antibacterial agents: bacterial topoisomerase inhibitors. | 2000-07 |
|
| The 2-pyridone antibacterial agents: 8-position modifications. | 1999-07 |
|
| In vivo efficacy of ABT-255 against drug-sensitive and -resistant Mycobacterium tuberculosis strains. | 1998-10 |
|
| The health status of paramedics children in Dr. Pirngadi Hospital Medan, Indonesia. | 1985-11-01 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
186293-38-9
Created by
admin on Mon Mar 31 22:36:48 GMT 2025 , Edited by admin on Mon Mar 31 22:36:48 GMT 2025
|
PRIMARY | |||
|
463888
Created by
admin on Mon Mar 31 22:36:48 GMT 2025 , Edited by admin on Mon Mar 31 22:36:48 GMT 2025
|
PRIMARY | |||
|
IMA7HK8V8X
Created by
admin on Mon Mar 31 22:36:48 GMT 2025 , Edited by admin on Mon Mar 31 22:36:48 GMT 2025
|
PRIMARY |
ACTIVE MOIETY